ZNF736P4Y

Across TCGA pan-cancer cohorts, ZNF736P4Y RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated ZNF736P4Y data layer.

The strongest signal is observed in lymphoid neoplasm diffuse large b-cell lymphoma (DLBC), where higher ZNF736P4Y RNA is associated with worse overall survival. In most high-consensus cancer types, elevated ZNF736P4Y expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

DLBC, KIRC, and STAD are the cancer types where ZNF736P4Y RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
DLBC	OS	Tertile	II,III,IV	0.099	0.731	.005	90	view →
KIRC	DFS	Tertile	II,III,IV	0.221	0.760	.017	54	view →
STAD	OS	Tertile	All	0.142	0.730	<.001	45	view →
CHOL	OS	Tertile	III,IV	0.024	0.772	.008	36	view →
KIRP	DFS	Tertile	All	0.455	0.619	<.001	36	view →
LIHC	OS	Tertile	II,III,IV	0.157	0.638	<.001	36	view →
ESCA	OS	Tertile	All	1.000	0.442	.036	18	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

ZNF736P4Y–DLBC (OS)

Open the DLBC breakdown →